Skip to content
Healthcare
KZActiveBIN 100940011543
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 17
To risks

ТОО "ЭСКУЛАП-VITA"

Director
Акбарова Динара Бауржановна
Incorporated
17.09.2010
Address
Шымкент ул. САЙРАМСКАЯ, Д.198Б
РНН
582400036407

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/17
Related-party risks

Found in government registries against the company’s director or founders. They do not affect the company’s own reliability score.

  • FounderАКБАРОВ БАУЫРЖАН ПЕРНЕБАЙУЛЫ
    Not present at its registered address
  • FounderКЫДЫРБАЕВА АШЕРКУЛЬ УМЕРБАЕВНА
    Not present at its registered address

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ЭСКУЛАП-VITA"
BIN
100940011543
Status
Active
Director
Акбарова Динара Бауржановна
Registration date
17.09.2010
Activity
Общая врачебная практика
Legal address
Шымкент ул. САЙРАМСКАЯ, Д.198Б
VAT payer
Yes, since 07.07.2026
КАТО
791510000
РНН
582400036407
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Средние предприятия
Employees
от 101 до 150 чел.

Activities

1
86210primary

Общая врачебная практика

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
20.4M
2025
32.4M+5%
2024
30.8M+3%
2023
30M+39%
2022
21.6M+205%
2021
7.1M
·20.4M
2026year to date
+5%32.4M
2025
+3%30.8M
2024
+39%30M
2023
+205%21.6M
2022
·7.1M
2021
2026
Tax paid20,386,439 ₸
Penalty4,100 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid32,441,964 ₸
Penalty18,000 ₸
Fine553,765 ₸
VAT refund0 ₸
2024
Tax paid30,822,067 ₸
Penalty0 ₸
Fine810,570 ₸
VAT refund0 ₸
2023
Tax paid29,979,682 ₸
Penalty98,871 ₸
Fine237,817 ₸
VAT refund0 ₸
2022
Tax paid21,615,984 ₸
Penalty83,000 ₸
Fine294,237 ₸
VAT refund0 ₸
2021
Tax paid7,095,454 ₸
Penalty1,000 ₸
Fine335,455 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • АД

    Акбарова Динара Бауржановна

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "ЭСКУЛАП-VITA" (BIN 100940011543) is an active legal entity in Шымкент, registered in 2010 (16 years on the market). Primary activity — общая врачебная практика. Per open government registries as of November 8, 2026: 8 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 613,000 ₸. Automated screening found 2 risk indicators for "ЭСКУЛАП-VITA". Director on record — Акбарова Динара Бауржановна. Data current as of November 8, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.